![]() ![]() NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that it has completed the listing of the Ion PGM Dx next-generation sequencing system with the US Food and Drug Administration as a Class II medical device.Īs Clinical Sequencing News reported in June, Thermo Fisher planned to register the Ion Torrent PGM with the FDA rather than go through the 510(k) process, as the instrument had the same intended use as Illumina's FDA-cleared MiSeqDx platform. Advances in Clinical Genomics Profiling.
0 Comments
Leave a Reply. |